In colon cancer, luteolin combined with erastin targets the tumor suppressor hypermethylated in cancer 1 (HIC1) gene, which inhibits GPX4 expression, thereby inducing ferroptosis; however, HIC1 regulation underlying ferroptosis remains unclear (Zheng et al., 2023). The gene discussed is HIC1; the disease is malignant colon neoplasm.